pdufa.bio

fasedienol

Page updated ·next FDA decision on the calendar ·Data as of Nov 5, 2026 9:00 PM ET

fasedienol is a Vistagen Therapeutics, Inc. program. Every date links its source.

VTGN catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Vistagen Therapeutics, Inc. (VTGN). We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Q3 2026VTGN

Questions

When is fasedienol's next FDA decision or readout?

No upcoming catalyst is on our calendar for fasedienol; no FDA decisions are on record below.

What happened at fasedienol's most recent FDA decision?

No FDA decision for fasedienol is in our archive yet.

Who makes fasedienol?

Vistagen Therapeutics, Inc. (VTGN).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.